Evidence map›Paper›PMID 38316797›Full record

ArticleNature communications2024

DynamicBind: predicting ligand-specific protein-ligand complex structure with a deep equivariant generative model.

Wei Lu, Jixian Zhang, Weifeng Huang, Ziqiao Zhang, Xiangyu Jia, Zhenyu Wang, Leilei Shi, Chengtao Li, Peter G Wolynes, Shuangjia Zheng

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed.

  1. ThebioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Machine Learning for RNA-Targeting Drug Design.Journal of chemical information and modeling · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Reimagining pharmacology education.Pharmacological reviews · 2026
    Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei Lu *Galixir Technologies, 200100, Shanghai, China. luwei0917@gmail.com.ORCID 0000-0002-1572-2909
Jixian Zhang *Galixir Technologies, 200100, Shanghai, China. jxzly1993@gmail.com.
Weifeng HuangSchool of Pharmaceutical Science, Sun Yat-sen University, 510006, Guangzhou, China.
Ziqiao ZhangGalixir Technologies, 200100, Shanghai, China.
Xiangyu JiaGalixir Technologies, 200100, Shanghai, China.
Zhenyu WangGalixir Technologies, 200100, Shanghai, China.
Leilei ShiGalixir Technologies, 200100, Shanghai, China.ORCID 0009-0000-7014-3347
Chengtao LiGalixir Technologies, 200100, Shanghai, China.
Peter G WolynesCenter for Theoretical Biological Physics and Department of Chemistry, Rice University, Houston, TX, 77005, USA.
Shuangjia Zheng *Global Institute of Future Technology, Shanghai Jiao Tong University, 200240, Shanghai, China. shuangjia.zheng@sjtu.edu.cn.ORCID 0000-0001-9747-4285

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While significant advances have been made in predicting static protein structures, the inherent dynamics of proteins, modulated by ligands, are crucial for understanding protein function and facilitating drug discovery. Traditional docking methods, frequently used in studying protein-ligand interactions, typically treat proteins as rigid. While molecular dynamics simulations can propose appropriate protein conformations, they're computationally demanding due to rare transitions between biologically relevant equilibrium states. In this study, we present DynamicBind, a deep learning method that employs equivariant geometric diffusion networks to construct a smooth energy landscape, promoting efficient transitions between different equilibrium states. DynamicBind accurately recovers ligand-specific conformations from unbound protein structures without the need for holo-structures or extensive sampling. Remarkably, it demonstrates state-of-the-art performance in docking and virtual screening benchmarks. Our experiments reveal that DynamicBind can accommodate a wide range of large protein conformational changes and identify cryptic pockets in unseen protein targets. As a result, DynamicBind shows potential in accelerating the development of small molecules for previously undruggable targets and expanding the horizons of computational drug discovery.

Indexed as

Molecular Dynamics SimulationProteinsDrug DiscoveryLigandsMolecular Docking SimulationProtein BindingProtein ConformationLigandsProteins

Identifiers

PMID38316797
PMCPMC10844226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.